These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 7783509)

  • 21. [Statin prevents coronary disease. The 4S study changes the therapeutic practice].
    Olsson AG
    Lakartidningen; 1995 Mar; 92(9):838, 843-4. PubMed ID: 7885109
    [No Abstract]   [Full Text] [Related]  

  • 22. HMGCoA reductase inhibitors lovastatin and simvastatin in the treatment of hypercholesterolemia after renal transplantation.
    Castelao AM; Griñó JM; Andrés E; Gilvernet S; Serón D; Castiñeiras MJ; Roca M; Galcerán JM; González MT; Alsina J
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1043-6. PubMed ID: 8442035
    [No Abstract]   [Full Text] [Related]  

  • 23. Statins and coronary artery disease--it's the clinical endpoints that count.
    Jackson G
    Br J Clin Pract; 1997; 51(1):2-3. PubMed ID: 9158261
    [No Abstract]   [Full Text] [Related]  

  • 24. Secondary prevention in coronary heart disease. Fact: lowering cholesterol saves lives.
    McKenna CJ; Sugrue DD
    Ir Med J; 1995; 88(6):191. PubMed ID: 8575912
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia.
    Frohlich J; Brun LD; Blank D; Campeau L; Crockford P; Curnew G; Dafoe W; Davignon J; Dufour R; Emery G
    Can J Cardiol; 1993 Jun; 9(5):405-12. PubMed ID: 8348392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Use of hydroxymethylglutaryl coenzyme A reductase inhibitors in patients with post-transplantation hyperlipemia].
    Martínez-Castelao A
    Med Clin (Barc); 1995 Nov; 105(18):719. PubMed ID: 8538262
    [No Abstract]   [Full Text] [Related]  

  • 27. [The 4S study is convincing--without explanation].
    Wennmalm A
    Lakartidningen; 1995 Mar; 92(9):844-6. PubMed ID: 7885110
    [No Abstract]   [Full Text] [Related]  

  • 28. Hypercholesterolemia treatment in a renal transplant patient.
    Devuyst O; Goffin E; Pirson Y; van Ypersele de Strihou C
    Clin Nephrol; 1994 May; 41(5):319. PubMed ID: 8050214
    [No Abstract]   [Full Text] [Related]  

  • 29. Petechial eruptions due to simvastatin in a patient with diabetes mellitus and liver cirrhosis.
    Horiuchi Y; Maruoka H
    J Dermatol; 1997 Aug; 24(8):549-51. PubMed ID: 9301152
    [No Abstract]   [Full Text] [Related]  

  • 30. Recent developments in coronary heart disease prevention: the Scandinavian and west of Scotland studies.
    Elam MB; Cushman W; Applegate WB; Heimberg M
    Tenn Med; 1997 May; 90(5):189-92. PubMed ID: 9130876
    [No Abstract]   [Full Text] [Related]  

  • 31. Fenofibrate, probucol, and other lipid-lowering treatments in heart transplant recipients.
    de Lorgeril M; Boissonnat P; Salen P; Monjaud I; Dureau G
    J Heart Lung Transplant; 1996 May; 15(5):539-40. PubMed ID: 8771511
    [No Abstract]   [Full Text] [Related]  

  • 32. [Efficacy and tolerability of simvastatin and omega-3 fatty acid combination in patients with coronary disease, hypercholesterolemia and hypertriglyceridemia].
    Tomei R; Rossi L; Carbonieri E; Franceschini L; Cemin C; Ghebremariam-Tesfau K; Zardini P
    Cardiologia; 1993 Dec; 38(12):773-8. PubMed ID: 8200011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperlipidaemia and cardiovascular disease.
    Buchalter M
    Curr Opin Lipidol; 1997 Jun; 8(3):U40-1. PubMed ID: 9211073
    [No Abstract]   [Full Text] [Related]  

  • 34. Stain therapy and reduced incidence of stroke. Implications of cholesterol-lowering therapy for cerebrovascular disease.
    Gotto AM
    Arch Intern Med; 1997 Jun; 157(12):1283-4. PubMed ID: 9201001
    [No Abstract]   [Full Text] [Related]  

  • 35. Beneficial effects of simvastatin may be due to non-lipid actions.
    Ravnskov U
    BMJ; 1995 Nov; 311(7017):1436-7. PubMed ID: 8520302
    [No Abstract]   [Full Text] [Related]  

  • 36. Nephrotic syndrome and simvastatin.
    Thomas M; Moorhead JF
    Lancet; 1990 Jun; 335(8701):1344-5. PubMed ID: 1971403
    [No Abstract]   [Full Text] [Related]  

  • 37. [Cardiovascular pharmacology (VIII). The role of HMG CoA reductase inhibitors in the current treatment of hyperlipidemias].
    Carmena R
    Rev Esp Cardiol; 1995 Jan; 48(1):59-65. PubMed ID: 7878284
    [No Abstract]   [Full Text] [Related]  

  • 38. [Heart Protection Study].
    Larsen ML; Hildebrandt PR
    Ugeskr Laeger; 2002 Jan; 164(3):348. PubMed ID: 11816337
    [No Abstract]   [Full Text] [Related]  

  • 39. [Simvastatin and pregnancy].
    Freyssinges C; Ducrocq MB
    Therapie; 1996; 51(5):537-42. PubMed ID: 9138389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study.
    Pedersen TR; Berg K; Cook TJ; Faergeman O; Haghfelt T; Kjekshus J; Miettinen T; Musliner TA; Olsson AG; Pyörälä K; Thorgeirsson G; Tobert JA; Wedel H; Wilhelmsen L
    Arch Intern Med; 1996 Oct; 156(18):2085-92. PubMed ID: 8862101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.